Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001
First investigational inhaled ENaC blocker to deliver clinically relevant and [...]
Nuclera launches antibody triage service to advance AI-driven antibody discovery
Rapid binder triage, of AI-driven candidate sets, enables early elimination [...]
Calla Lily Clinical Care doses first patients in clinical trial for intravaginal drug delivery platform for threatened miscarriage
FREEDOM study to evaluate progesterone delivery using Callavid intravaginal platform [...]
FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media
Collaboration results in platform to help researchers overcome challenges in [...]
Bio-Rad Expands Range of TrailBlazer Kits for Antibody Conjugation to StarBright Dyes
Expanded Range Increases Access to Bio-Rad’s StarBright™ Dyes for Flow [...]
Qureight establishes Scientific Advisory Board focused on pulmonary hypertension
Global industry experts in pulmonary diseases appointed: Marc Humbert, Steven [...]
Lab Thread introduces Unified Lab Software Platform to streamline biological research
Connects scientific teams, data and workflows within a single, fully [...]
EpilepsyGTx appoints Professor Dimitri Kullmann as Chief Scientific Officer
Appointment of UCL Neurologist will accelerate the delivery of novel [...]
Bio-Rad Launches PTC Harmony 96 and PTC Harmony Deepwell Thermal Cyclers
New PTC Harmony Thermal Cycler Line Expands Access to Reliable, [...]
PlaqueTec closes $5 million financing
Oversubscribed round backed by existing shareholders Investment will support development [...]